AstraZeneca diabetes drug approved for use in Scotland
November 11, 2014Sales and Marketing Afinitor, AstraZeneca, Eylea, Onglyza, Perjeta, SMC, diabetes, type 2
The Scottish Medicines Consortium (SMC) has shown AstraZeneca’s Onglyza (saxagliptin) the green light to be used with insulin in patients …
inVentiv Health president joins from eBay
November 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv Health, jeff wilks
Life sciences services company inVentiv Health has announced the appointment of Jeffrey Wilks as the president of its advertising businesses. …
UCB sells generics business
November 10, 2014Manufacturing and Production, Sales and Marketing Belgium, UCB, generics, kremers urban, us conern
UCB is to sell its US generics business Kremers Urban to two private equity firms in a $1.5 billion deal. …
Novartis to present inflammatory data
November 10, 2014Business Services AS, Novartis, PSA, Secukinumab, acr
Novartis is to present data from four pivotal Phase III trials in two debilitating inflammatory diseases at the American College …
BMS claims advance with hepatitis C regimen
November 10, 2014Research and Development, Sales and Marketing BMS, Gilead, HCV, dcv-trio, hep C, hepatitis C, liver, sovaldi
Bristol-Myers Squibb has reported data for its hepatitis C virus cocktail that it says outperforms even newer all-oral therapies in …
Working Life: Shire’s Mark Rus
November 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Working Life, mark rus, neuroscience
How did you find your way into your current role? After completing an MSc in Economics at the London School …
Chief executive promotion at myoscience
November 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jeffrey gold, myoscience
Californian medical device firm myoscience has appointed Jeffrey Gold as its chief executive. Gold who was the president and chief …
New editor for Pharmafocus named
November 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, lilian anekwe, pharmafile
Lilian Anekwe has been named as the new editor for the Pharmafocus and Pharmafile brands, and joins the publishing team …
EU and drug industry set aside €280m for Ebola
November 7, 2014Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west
The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …
Doctors must help NHS save money, says report
November 7, 2014Medical Communications, Sales and Marketing Academy of Medical Royal Colleges, GPs, NHS, government, hospitals
A report has suggested the National Health Service could make nearly £2 billion in cost savings if doctors ‘provided more …
Perrigo acquires Omega for $4.5 billion
November 7, 2014Manufacturing and Production, Sales and Marketing Actavis, Boehringer Ingelheim, Boehringer Ingelheim., Elan, Perrigo, Sanofi, omega
In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …
Why use a specialised mother-tongue translator?
November 7, 2014“Translation is that which transforms everything so that nothing changes.” Günter Grass The art of a good translation is to …
Two senior appointments for MJL
November 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mjl, nicky oates, nina buckley
UK healthcare agency MJL has made two appointments in Nina Buckley as managing director and Nicky Oates as a senior …
Connect with SHL through our newest Podcast Series
November 7, 2014Sales and Marketing auto injector podcast, auto injector testing, shl podcasts
To help customers better understand SHL products and services, a suite of communication tools including articles, white papers, case studies, …
App could crack fake antimalarial drugs market
November 6, 2014Medical Communications, Sales and Marketing Apple, antimalarial, app, colourassist, malaria, talanta
A cheap iPhone app developed last year has demonstrated high-level effectiveness towards identifying bogus antimalarial treatments. A recent study published …
Lundbeck sales slide as generic competition bites
November 6, 2014Sales and Marketing Ebixa, Lundbeck, Q3, Xenazine, generic, onfi, sabril
Lundbeck’s sales fell dramatically in the third quarter of 2014 as it struggles with expiring patents, although several of its …
Allergan and Valeant trade blows as shareholder meeting looms
November 6, 2014Sales and Marketing Actavis, Allergan, Forest, Valeant, merger, warner
Allergan’s efforts to block a key supporter of Valeant’s hostile takeover bid from voting at next month’s special shareholder meeting …
Consumers want more from wearables market
November 6, 2014Medical Communications, Sales and Marketing Apple, Microsoft, Samsung, mhealth, pwC, watch, werables
The interest in mobile health (mHealth) wearables is gaining traction, but consumers want more affordable devices that offer greater engagement …
Roche unveils plans for first Asian diagnostics plant
November 6, 2014Medical Communications, Sales and Marketing Asia-Pacific, China, Roche, asia pacific, asian, manufacturing
Roche has said it will invest 450 million Swiss francs ($468m) in the construction of a diagnostics manufacturing facility in …
ROCK medical communications appoints MD
November 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, ROCK, terence bradley
ROCK medical communications has appointed Terence Bradley to be its managing director. Most recently Bradley was the founding director of …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
